Select Page

ABOUT NORLASE

WHO WE ARE

Norlase is an emerging global ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease. Norlase is comprised of worldwide industry leaders and experts in ophthalmology, laser technology, medical device development and customer care.

WHO WE ARE

Norlase is an emerging global ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease. Norlase is comprised of worldwide industry leaders and experts in ophthalmology, laser technology, medical device development and customer care.

OUR VISION IS SIMPLE

We innovate to improve the lives of ophthalmologists and patients worldwide. We’re dedicated and passionate about addressing the needs of ophthalmologists and improving practice efficiency, patient care and physician convenience.

We also believe that no one can achieve this on their own, which is why we work closely with a network of ophthalmologists and industry leaders. Together, we can change ophthalmic care for the better.

OUR VISION IS SIMPLE

We innovate to improve the lives of ophthalmologists and patients worldwide. We’re dedicated and passionate about addressing the needs of ophthalmologists and improving practice efficiency, patient care and physician convenience.

We also believe that no one can achieve this on their own, which is why we work closely with a network of ophthalmologists and industry leaders. Together, we can change ophthalmic care for the better.

MANAGEMENT TEAM

MANAGEMENT TEAM

Oliver is a cofounder of Norlase, which started as a university research project and is now delivering superior solutions to the ophthalmic industry. As a leader and innovator, Oliver is devoted to creating and introducing premiere products born from a culture of quality, transparency and dedication.

Greg Fava brings over 25 years of ophthalmic laser experience to Norlase, having previously held positions at IRIDEX, Optimedica, and Topcon Medical Laser Systems. His experience in working directly with ophthalmic industry experts provided an understanding of the features needed to create impactful and
disruptive products. 

Andrew Berkowitz has spent over 30 years in ophthalmic sales, launching 32 products and holding multiple sales management positions. He was a pivotal part of the teams launching paradigm shifting products, including the first true solid-state laser (IRIDEX), the first pattern scanning laser (Optimedica),
and now LEAF. 

High-tech entrepreneur Peter M. W. Skovgaard co-founded Norlase and has been instrumental in building the company and developing our next-generation laser technology. A PhD in high-power semiconductor lasers, Peter has over 20 years of experience in bringing photonics technology from research to market at companies such as GIGA (acquired by Intel), NKT Photonics and Kaleido.

Top laser scientist and innovator Danny Noordegraaf was hand-picked from Denmark’s largest laser manufacturer to run Norlase’s technology development.  Danny has more than 40 scientific publications within photonics and laser technology and was awarded Researcher of the Year by the Danish Optical Society in 2011. As CTO, Danny has spearheaded the technological breakthroughs behind the LEAF green laser system.

Coming from a position as Quality Director in the global med-tech company Oticon, Jan joined Norlase in 2018. He has managed the establishment of Norlase’s rigorous Quality Management System, ensuring that every product lives up to the highest quality standard. Jan also led the successful efforts to obtain FDA clearance for the LEAF laser system.

ADVANCE YOUR CAREER

ADVANCE YOUR CAREER

We can’t fulfill our mission and deliver innovation without the best talent and brightest minds in the industry.
To advance your career, contact us!